Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | G6PD | P11413 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3655957 | 0.89 | ALDH1A1 (0.57) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL7628912 | 0.85 | ALDH1A1 (0.51) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL9322109 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL9132689 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL5593583 | 0.83 | ALDH1A1 (0.68) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL1879713 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL9321009 | 0.82 | ALDH1A1 (0.62) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| SCHEMBL7307539 | 0.81 | MAPT (0.70) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| Hydrochloric Acid SCHEMBL9320078 | 0.81 | ALDH1A1 (0.96) | ALDH1A1MAPTG6PDHPGDALOX15 | |
| Hydrochloric Acid SCHEMBL11708748 | 0.79 | ALDH1A1 (0.93) | ALDH1A1MAPTG6PDHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | GIRONDA KEVIN F (US) | 2002-09-12 | — | — | US | claimed |
| EP-0540213-B1 | Bromate as an inhibitor of nitrosamine formation in nitrate stabilized isothiazolones | ROHM & HAAS (US) | 1996-10-30 | — | — | EP | claimed |
| EP-0542408-B1 | Bromate stabilizers for 3-isothiazolones | ROHM & HAAS (US) | 1996-01-10 | — | — | EP | claimed |
| EP-0542408-A1 | Bromate stabilizers for 3-isothiazolones | ROHM AND HAAS COMPANY (US) | 1993-05-19 | — | — | EP | claimed |
| EP-0540213-A1 | Bromate as an inhibitor of nitrosamine formation in nitrate stabilized isothiazolones | ROHM AND HAAS COMPANY (US) | 1993-05-05 | — | — | EP | claimed |
| EP-2207416-B1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | IMERYS FILTRATION MINERALS INC (US) | 2018-11-07 | — | — | EP | disclosed |
| US-20100239679-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | WORLD MINERALS, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| EP-2207416-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | World Minerals, Inc. (US) | 2010-07-21 | — | — | EP | disclosed |
| WO-2009045941-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | WORLD MINERALS, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-12-07 | — | — | US | disclosed |
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | GIRONDA KEVIN F (US) | 2002-09-12 | — | — | US | disclosed |
| EP-1219172-A1 | Halocyanoacetamide antimicrobial compositions | ROHM AND HAAS COMPANY (US) | 2002-07-03 | — | — | EP | disclosed |
| EP-0410726-A1 | S-substituted beta-thioacrylamides and their use as microbicides | ROHM AND HAAS COMPANY (US) | 1991-01-30 | — | — | EP | disclosed |
| EP-0356801-A1 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1990-03-07 | — | — | EP | disclosed |
| EP-0331319-A1 | Method for the formation of images | KONICA CORPORATION (JP) | 1989-09-06 | — | — | EP | disclosed |
| EP-0090584-B1 | LIGHT-SENSITIVE SILVER HALIDE PHOTOGRAPHIC MATERIAL | KONICA CORPORATION (JP) | 1986-12-03 | — | — | EP | disclosed |
| US-4490462-A | CONTAINING ISOTHIAZOLIN-3-ONE MICROBIOCIDE OR FUNGICIDE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-12-25 | — | — | US | disclosed |
| EP-0090584-A2 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1983-10-05 | — | — | EP | disclosed |
| US-4165318-A | AGAINST CHEMICAL DECOMPOSITION OF THE 3-ISOTHIAZOLONE MILDEW CONTROLLING AGENT | ROHM AND HAAS COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
| US-4129448-A | A 3-ISOTHIAZOLONE | ROHM AND HAAS COMPANY (US) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | ENPP1, ENPP3, SMPD1 | ALDH1A1 2504/4885MAPT 4463/4885G6PD 271/4885 |
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | HDHD5, DGKI, DAGLA | ALDH1A1 2941/4885MAPT 3278/4885G6PD 3211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.